IRX Therapeutics
About:
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
Website: https://www.brooklynitx.com
Description:
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases. IRX Therapeutics’ is focused on making cancer treatments better. The lead platform technology, IRX-2, is thought to broadly restore the immune system by overcoming cancer-induced immune suppression. The Company believes that its products can play an important role in helping a wide range of cancer treatments improve and extend the lives of patients. It was founded in 1994 and is headquartered in New York.
$128M
$10M to $50M
New York, New York, United States
1994-01-01
John Hadden
11-50
2017-08-29
Private
© 2025 bioDAO.ai